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Objective: To evaluate the effect of ethanolic extract of Phyllanthus niruri.Linn (Euphorbiaceae) 
on experimentally induced burn wound model in rats and to evaluate whether it reverses the 
wound healing in steroid suppressed rats. Methods: Two models including burn wound model 
and dexamethasone suppressed burn wound model were used in the study. The formulations of 
ethanolic extract of Phyllanthus niruri were prepared in gum acacia at 8% and in ointment base 
at 10% and were administered orally (400 mg/kg) and externally respectively. The parameters 
studied were the wound contraction and the period of epithelialisation. Results: In burn wound 
model, oral and topical administration of Phyllanthus niruri did not show any significant effects 
in wound contraction and period of epithelialisation when compared to control. In dexamethasone 
suppressed burn wound model, wound contraction rate was increased significantly by topical (P 
< 0.001) and oral (P < 0.001) administrations of Phyllanthus niruri by about 47.57% and 26.16% 
respectively. Topical administration has shown significant (P < 0.05) enhancement of wound 
contraction than oral dosage form. Dexamethasone depressed epithelialisation period was reversed 
significantly by topical (P < 0.0001) and oral (P <0.001) administrations of Phyllanthus niruri 
by about 32.5% and 21.3% respectively. Conclusions: Both topical and oral administrations 
of ethanolic extract of Phyllanthus niruri are found to reverse dexamethasone suppressed burn 
wound healing. 
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1. Introduction
  The management of burn injury in patients having poor 
healing mechanism is one of the greatest challenges in 
clinical practice. Complications may deepen the depth 
of injury or convert a partial-thickness burn to a full-
thickness injury [1]. Poor wound healing is observed either 
due to certain catabolic diseases like chronic diabetes 
mellitus or due to long term glucocorticoid therapy for 
various ailments. Thus it is essential to develop drugs 
which enhance wound healing mechanisms. Several drugs 
obtained from herbs are known to hasten the healing of 
wounds. The wound healing efficacy of certain traditionally 
used herbs remains unexplored.   
  The commonly available herb Phyllanthus niruri.Linn 
(Euphorbiaceae) is used traditionally in India for its 
medicinal properties. This herb was reported to possess 
anti-inflammatory[2], antifungal, antiviral, antibacterial[3], 
antioxidant, hepatoprotective[4],  hypoglycemic[5], 
hypotensive, analgesic activities [6], inhibitory effect on 
renal stone formation etc[7]. The plant contain acidic 
arabinogalactan[8], diterpenes[9], alkaloids, flavonoids, 
l ignans, tannins, terpenes [10],  hypophyllanthin, 
phyllanthin[11] etc. In the present study, we evaluated the 
effect of Phyllanthus niruri on burn wound and steroid 
suppressed burn wound healing by oral and topical 
administration. 
2. Materials and methods
2.1. Experimental animals
  Male albino wistar rats weighing 250-300 g were used. 
The animals were caged individually after making burn 
wound till completion of wound healing. In each group six 
animals were used. The experimental protocol was approved 
by Institutional Animal Ethics Committee and animals 
were maintained under standard conditions in animal house 
approved by the Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA). 
2.2. Drugs and chemicals
  Ketamine injection was obtained from Neon Laboratories 
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Limited (Mumbai, India), Silver sulphadiazine was obtained 
from Kasturba Hospital Pharmacy (Manipal), dexamethasone 
was obtained from Zydus Alidac (Ahmedabad) and Gum 
acacia was obtained from Nice Chemicals Ltd (Cochin). 
Dried Phyllanthus niruri was purchased from local market 
and authenticated by Department of Pharmacognosy, 
MCOPS, Manipal. Voucher specimen was kept in the 
department. 
2.3. Preparation of extract
  A finely macerated dried whole plant, weighing 500 grams, 
was soaked in ethanol measuring 3 liters approximately, 
in a 5 liter round flask for about 24 hours. After 24 hours, 
extraction was started by reflux condensation at 60-80 ℃. 
The process was done for 3 hours. Then it was cooled and 
the ethanol was drained using a muslin cloth into a conical 
flask. Then, fresh absolute ethanol was put into the round 
bottom flask containing the plant material. The same 
procedure of reflux condensation was repeated twice with 3 
liters of ethanol each time. The ethanol recovered from these 
three batches, that is, the extract measuring approximately 
nine liters was concentrated under reduced pressure by 
distillation till it acquired a syrupy consistency. Finally, the 
extract from three batches was mixed in a big china dish and 
evaporated to dryness on a water bath, later; it was weighed 
to find out the yield.
2.4. Burn wound
  Partial thickness burn wounds were made on overnight-
fasted animals under ketamine (50 mg/kg, IM) anesthesia 
by pouring hot molten wax (2 g) at 80 ℃ [12]. The wax was 
poured on the shaven back of the animal through a cylinder 
of 300 mm2 circular opening. The wax was allowed to remain 
on the skin for 8 minutes by which time it got solidified. 
This was day 0. 
  In dexamethasone suppressed burn model, dexamethasone 
was administered from day 0 (0.17 mg/kg, I.P) and was 
continued on subsequent days till the day of eschar falling [13]. 
2.5. Selection of doses and treatment period
 The dose selected was 400 mg/kg body weight of rat 
after doing acute toxicity study. For oral administration, 
suspension of ethanol extract (8%) was prepared using 2% 
gum acacia. For topical application, ointment of ethanol 
extract (10%) was prepared using simple ointment base. 
The drugs were administered once daily from day 1 and 
continued till the day of falling of eschar in both models.
2.6. Study design 
  Burn wound model and dexamethasone suppressed burn 
wound model were used to asses the wound healing property 
of Phyllanthus niruri in rats. Four and three groups of 
animals were used for burn model and dexamethasone 
suppressed burn model respectively. There were six animals 
in each group. The drug treatment was as follows: 
For Burn Wound Model:
Group 1:  Gum acacia (2%) 2 mL by oral (Control);
Group 2:  Silver sulphadiazine (0.5g of 1%) cream, topical;
Group 3:  Phyllanthus niruri extract (400 mg/kg) oral;
Group 4: Phyllanthus niruri extract (10%) topical; 
For dexamethasone suppressed burn wound model:
Group 5: Dexamethasone (0.17 mg/kg, I.P) (DEXA group);
Group 6: Dexamethasone (0.17 mg/kg, I.P) and Phyllanthus 
niruri extract (10%) topical;
Group 7: Dexamethasone (0.17 mg/kg, I.P) and Phyllanthus 
niruri extract (400 mg/kg) oral.
2.7. Evaluation of burn wound healing activity
  Burn wound model was utilized to evaluate the rate 
of wound contraction and the time required to full 
epithelialisation of the wound. 
2.7.1. Wound contraction rate
  Wound area was measured by tracing the wound on a 
transparent butter paper on every alternate day of post-
wounding. The tracing was then transferred to 1 mm2 
graph sheets, from which the wound area was evaluated. 
The evaluated surface was then employed to calculate the 
percentage of wound contraction, taking the initial size of 
wound 300 mm2 as 100% by using the following equation:       
                      
% of wound contraction                                         
              Initial wound size - Specific day wound size
 = 
                       Initial wound size                                       
伊 100
  For the analysis of serial measurements of wound 
contraction on each subject on different days, the Area 
Under Curve (AUC) [14] of each subject was calculated. The 
AUC was calculated by adding the areas under the graph 
between each pair of consecutive observations obtained from 
percentage of wound contraction. If we have measurements 
y1 and y2 at times t1 and t2, then the AUC between those two 
times is the product of the time difference and the average 
of the two measurements. Thus we get (t2-t1). (y1+y2)/2. If we 
have n+1 measurements yi at times ti (i=0, 1, 2...... n), then 
the AUC is calculated as: 
   Thus percentage of wound contraction was converted 
in to Area Under Curve. In burn wound model, the % 
enhancement of wound contraction rate was calculated by 
taking AUC of control group as 100% and by using the 
following formula:
  
 % Enhancement of wound contraction rate
        AUC of Control group - AUC of Phyllanthus niruri group
                                                                                     ×100       
 
=
                           AUC of Control group                  
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  In steroid suppressed burn model, taking the AUC of 
DEXA group as 100%, the percentage enhancement of 
wound contraction rate was calculated.   
  
2.7.2.  Period of epithelialisation 
  Falling of the eschar leaving no raw wound behind was 
taken as end point of complete epithelialisation and the days 
required for this was taken as period of epithelialisation. 
Percentage decrease in period of epithelialisation was 
calculated by the same formula as in % enhancement of 
wound contraction rate.  
2.8. Statistical analysis
  Results were expressed as mean 依 SEM. The differences 
between experimental groups were compared using one-
way Analysis of Variance (ANOVA) followed by Posthoc 
Test viz Tukey Alpha (0.05). The results were considered 
statistically significant at P<0.05.
3. Results 
3.1. Wound contraction rate
  In burn wound model, oral and topical administrations of 
Phyllanthus niruri did not show any significant in wound 
contraction compared to control and silver sulphadiazine 
treated groups (Table1).
  In dexamethasone suppressed burn wound model, wound 
contraction rate was increased significantly by topical (P< 
0.001) and oral (P<0.001) administration of Phyllanthus 
niruri by about 47.57 % and 26.16% respectively. Topical 
administration has shown significant (P<0.05) enhancement 
of wound contraction than oral administration. (Table 1, 
Figure 1).
3.2 Period of epithelialisation
In burn wound model, oral and topical administrations 
of Phyllanthus niruri did not reduce the period of 
epithelialisation compared to control and Silver 
sulphadiazine treated groups (Table 2).
  In dexamethasone suppressed burn wound model, 
topical (P<0.0001) and oral (P<0.001) administration of 
Phyllanthus niruri significantly reversed dexamethasone 
depressed epithelialisation period by about 32.5% and 
21.3% respectively (Table 2, Figure 1).
Figure 1. Steroid suppressed burn wound model:  Effect of 
Phyllanthus niruri in reversing the delaying of wound contraction rate 
and epithelialisation period.
From burn wound model: A = Control group; 
From dexamethasone suppressed burn model: D=Dexamethasone 
induced delaying in wound healing, B= Dexamethasone + Phyllanthus 
niruri topical,  C = Dexamethasone + Phyllanthus niruri oral. 
Table 1
Burn wound model--effect of Phyllanthus niruri on wound contraction rate. 
Groups  Drugs Dose & Route
% Wound contraction
(Mean  依  SEM)
% Enhancement 
of wound contraction
Group 1 Gum acacia  2 mL, Oral  284.95 依 139.14 -
Group 2 Silver Sulphadiazine    1%, Topical 1 175.62 依 65.60 8.56
Group 3  Phyllanthus niruri       400 mg/kg, Oral 1 267.48 依 165.77 1.36
Group 4 Phyllanthus niruri       10%, Topical 1 573.35 依 225.59 -22.45
Group 5 Dexamethasone 0.17 mg/kg, I.p 3 617.44 依 208.05 -
Group 6 
Dexamethasone +
Phyllanthus niruri
0.17 mg/kg, I.p+400 mg/kg,
Oral
1 896.75依194.55a,c 47.57
Group 7 
Dexamethasone +
Phyllanthus niruri
0.17 mg/kg, I.p+10%,
Topical
2 671.14 依131.44b 26.16
n=Number of animals in each group = 6; compared to dexamethasone group; compared to dexamethasone group, aP<0.0001, bP<0.001 
compared to dexamethasone + Phyllanthus niruri topical group, ;cP<0.05. [ANOVA was followed by Posthoc Test viz Tukey Alpha (0.05)].% 
contraction values are converted into Area Under Curve.
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Table 2 
Burn wound model-effect of Phyllanthus niruri on period of epithelialisation.
Groups Drugs Dose & Route 
 Period of epithelialisation 
(Mean 依 SEM)
 % enhancement
of epithelialisation period
Group 1 Gum acacia   2 mL, Oral 24.50依 2.34 -
Group 2  Silver sulphadiazine   1%, Topical 21.00 依 1.15 14.29
Group 3 Phyllanthus niruri   400 mg/kg, Oral 21.50 依 1.56 12.25
Group 4 Phyllanthus niruri   10%, Topical 26.16 依 2.83 -6.77
Group 5 Dexamethasone 0.17 mg/kg, I.p 56.33 依 1.89 -
Group 6 Dexamethasone +
Phyllanthus niruri
0.17 mg/kg, I.p + 400 mg/kg, 
Oral
 36.50 依 1.45d 32.5
Group 7 Dexamethasone +
Phyllanthus niruri
0.17 mg/kg, I.p +10%,
Topical
44.33 依 1.52e 21.3
n=Number of animals in each group = 6; compared to dexamethasone group, dP<0.0001; compared to dexamethasone group, eP <0.001; 
[ANOVA was followed by Posthoc Test viz Tukey Alpha (0.05)].
4. Discussion 
  Initial inflammatory phase, proliferation & migration of 
epithelial cells, granulation tissue formation and wound 
contraction are the main phases of burn wound repair 
mechanism. Neovascularisation takes place under the 
influence of vascular endothelial growth factor (VEGF). 
Platelet-derived growth factor (PDGF), transforming growth 
factor-毬(TGF-毬), basic fibroblast growth factor (bFGF) 
and cytokines are the factors which are associated with 
cellular proliferation [15]. In burn wound model, Phyllanthus 
niruri did not significantly alter healing of burn wound as 
compared to control. 
  Dexamethasone delays burn wound healing by reducing 
transforming growth factor-毬(TGF-毬), collagen & 
fibroblast deposition, neovascularisation and epithelial 
migration in wounds[16-18]. Hence, decreased wound 
contraction rate and delaying in period of epithelialisation 
were observed in dexamethasone suppressed burn wound 
model. In dexamethasone suppressed burn wound model, 
topical or oral administration of Phyllanthus niruri 
significantly increased wound contraction rate and enhanced 
the period of epithelialisation. 
  Since Phyllanthus niruri enhances steroid suppressed 
wound healing significantly, it could be used as a supportive 
therapy to treat chronic wounds in catabolic diseases like 
diabetes mellitus etc. Though mechanism of action of 
Phyllanthus niruri responsible for the reversal of steroid 
suppression in healing was not studied, yet it could be the 
objective of further studies. 
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